Cart
sales@molnova.com
Semapimod hydrochloride
CAS No. 164301-51-3
Semapimod hydrochloride( CNI 1493 | AXD-455 )
Catalog No. M12498 CAS No. 164301-51-3
Semapimod (CNI 1493;AXD-455) is a tetravalent guanylhydrazone that acts as a selective inhibitor of cytokine-inducible arginine transport and NO production.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 242 | Get Quote |
|
| 25MG | 410 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSemapimod hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionSemapimod (CNI 1493;AXD-455) is a tetravalent guanylhydrazone that acts as a selective inhibitor of cytokine-inducible arginine transport and NO production.
-
DescriptionSemapimod (CNI 1493;AXD-455) is a tetravalent guanylhydrazone that acts as a selective inhibitor of cytokine-inducible arginine transport and NO production, inhibits TLR4 signaling (IC50=0.3 uM) by targeting the TLR chaperone gp96; does not inhibit EDRF activity, inhibits nitric oxide synthesis by inflammatory macrophages; prevents the development of carrageenan-induced footpad inflammation, and conferred protection against lethal LPS challenge in mice.Irritable Bowel Syndrome Phase 2 Clinical.
-
In Vitro——
-
In VivoAnimal Model:Male OZ rats Dosage:5 mg/kg Administration:I.p; daily for 2 weeks Result:Restored endothelium-dependent vasorelaxation in OZ rats.Animal Model:C57Bl/6 mice (GL261 cells were orthotopically implanted) Dosage:6 mg/kg/day Administration:Intracranially for 1 week, delivered via an osmotic pump Result:Inhibited tumor cell invasion by more than 75%.
-
SynonymsCNI 1493 | AXD-455
-
PathwayImmunology/Inflammation
-
TargetTLR
-
RecptorTLR
-
Research AreaOther Indications
-
IndicationIrritable Bowel Syndrome
Chemical Information
-
CAS Number164301-51-3
-
Formula Weight890.746
-
Molecular FormulaC34H56Cl4N18O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 2.17 mg/mL (2.44 mM)
-
SMILESCC(=NN=C(N)N)C1=CC(=CC(=C1)NC(=O)CCCCCCCCC(=O)NC2=CC(=CC(=C2)C(=NN=C(N)N)C)C(=NN=C(N)N)C)C(=NN=C(N)N)C.Cl.Cl.Cl.Cl
-
Chemical NameN1,N10-bis(3-(1-(2-carbamimidoylhydrazono)ethyl)-5-(1-(2-carbamimidoylhydrazono)ethyl)phenyl)decanediamide tetrahydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bianchi M, et al. Mol Med. 1995 Mar;1(3):254-66.
2. Bianchi M, et al. J Exp Med. 1996 Mar 1;183(3):927-36.
3. Cohen PS, et al. Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):3967-71.
molnova catalog
related products
-
Loxoribine
Loxoribine is a guanosine analog. Loxoribine is an orally bioavailable and selective Toll-like receptor (TLR) 7 agonist. It has anti-viral and anti-tumor activities.Loxoribine is a potent new immunostimulant with a relatively broad spectrum of immunobiological activities.
-
Procyanidin B1
Procyanidin B1, isolated from commonly eaten fruits, binds to the TLR4/MD-2 complex and has anti-inflammatory activity.Procyanidin B1 (100 μg/mL) inhibits LPS-induced TNF-α production, and expression of MD-2, TRAF6, NF-κB mRNA, phosphorylated p38 MAPK and NF-κB protein in THP1 cells.
-
TLR4-IN-C34
TLR4-IN-C34 is an orally active TLR4 inhibitor and reduces systemic inflammation in models of endotoxemia and necrotizing enterocolitis.
